Assessment of lmage-guided Programming (IGP) on Bilateral STN and GPi Deep Brain Stimulation Programming Time Congratulations to Drs. Michael Okun and Kelly Foote on the publication of “Assessment of lmage-guided Programming (IGP) on Bilateral STN and GPi Deep Brain Stimulation Programming Time,” which appears in the April edition of Neurology. Abstract Objective: Assessment of Parkinson’s disease (PD) patient outcomes using an image-guided programming (IGP) applied during initial deep brain stimulation…
https://neurology.ufl.edu/2024..../04/22/assessment-of

Letter to the editor We read Ebina and colleagues' article with great interest [1]. Biomarker based classification of Parkinson's disease (PD) subtypes is a recently featured research topic [2], and the authors provided additional insights into the utility of 123I-metaiodobenzylguanidine (MIBG) scintigraphy in the PD subtype classification. However, abnormal MIBG uptake in the major salivary gland, one of their main results, seemed not specific for PD and needs further verification to discuss the pathophysiological implication of MIBG accumulation in the salivary glands.
https://www.jns-journal.com/ar....ticle/S0022-510X(24)

Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers https://www.nature.com/articles/s41531-024-00706-1

Efficacy of interstitial photodynamic therapy using talaporfin sodium and a semiconductor laser for a mouse allograft glioma model https://www.nature.com/articles/s41598-024-59955-y

Eye movement function captured via an electronic tablet informs on cognition and disease severity in Parkinson’s disease https://www.nature.com/articles/s41598-024-59750-9